KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Current Assets: 2009-2024

Historic Current Assets for Charles River Laboratories International (CRL) over the last 16 years, with Dec 2024 value amounting to $1.4 billion.

  • Charles River Laboratories International's Current Assets rose 2.50% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 2.50%. This contributed to the annual value of $1.4 billion for FY2024, which is 12.78% down from last year.
  • Charles River Laboratories International's Current Assets amounted to $1.4 billion in FY2024, which was down 12.78% from $1.6 billion recorded in FY2023.
  • Charles River Laboratories International's 5-year Current Assets high stood at $1.6 billion for FY2023, and its period low was $1.2 billion during FY2020.
  • In the last 3 years, Charles River Laboratories International's Current Assets had a median value of $1.4 billion in 2022 and averaged $1.5 billion.
  • Its Current Assets has fluctuated over the past 5 years, first grew by 17.61% in 2020, then fell by 12.78% in 2024.
  • Over the past 5 years, Charles River Laboratories International's Current Assets (Yearly) stood at $1.2 billion in 2020, then rose by 6.07% to $1.3 billion in 2021, then increased by 12.95% to $1.4 billion in 2022, then rose by 11.79% to $1.6 billion in 2023, then fell by 12.78% to $1.4 billion in 2024.